pMIA10.7
(Plasmid
#214451)
-
PurposeBxbI landing-pad Tet-On-T2A-puro-pA pA-GFP-TRE3G donor. Use with BxbI expressing plasmid to swap payload into 4.721 landing-pad. Generates inducible cell line.
-
Depositing Lab
-
Sequence Information
Ordering
Item | Catalog # | Description | Quantity | Price (USD) | |
---|---|---|---|---|---|
Plasmid | 214451 | Standard format: Plasmid sent in bacteria as agar stab | 1 | $85 |
Backbone
-
Vector backbonepMIA10.5-Clover
-
Backbone manufacturerin house
-
Vector typeBxbI donor
-
Selectable markersPuromycin
Growth in Bacteria
-
Bacterial Resistance(s)Ampicillin, 100 μg/mL
-
Growth Temperature37°C
-
Growth Strain(s)DH5alpha
-
Copy numberHigh Copy
Gene/Insert 1
-
Gene/Insert nameTet-On 3G
-
SpeciesSynthetic
-
Insert Size (bp)744
-
Tags
/ Fusion Proteins
- T2A (C terminal on insert)
- PuroR (C terminal on insert)
Gene/Insert 2
-
Gene/Insert namePuroR
-
SpeciesSynthetic
-
Insert Size (bp)600
-
Tags
/ Fusion Proteins
- T2A (N terminal on insert)
- Tet-On 3G (N terminal on insert)
Gene/Insert 3
-
Gene/Insert nameTRE3G CopGFP
-
SpeciesSynthetic
-
Insert Size (bp)1075
Resource Information
-
Supplemental Documents
-
A portion of this plasmid was derived from a plasmid made byTRE: pTRE3G (Clontech, 631173) copGFP-SV40pA: pMAX-GFP (Lonza) Tet-On: pCMV-Tet-On 3G (Clontech, 631335)
Terms and Licenses
-
Academic/Nonprofit Terms
-
Industry Terms
- Not Available to Industry
Trademarks:
- Zeocin® is an InvivoGen trademark.
These plasmids were created by your colleagues. Please acknowledge the Principal Investigator, cite the article in which the plasmids were described, and include Addgene in the Materials and Methods of your future publications.
-
For your Materials & Methods section:
pMIA10.7 was a gift from Roger Foo (Addgene plasmid # 214451 ; http://n2t.net/addgene:214451 ; RRID:Addgene_214451) -
For your References section:
Computationally defined and in vitro validated putative genomic safe harbour loci for transgene expression in human cells. Autio MI, Motakis E, Perrin A, Bin Amin T, Tiang Z, Do DV, Wang J, Tan JKM, Ding SSL, Tan WX, Lee CJM, Teo AKK, Foo R. Elife. 2024 Jan 2;13:e79592. doi: 10.7554/eLife.79592. 10.7554/eLife.79592 PubMed 38164941